Domov › Levkemija › Kalifornija

Klinične študije za Levkemija v Kalifornija

28 študij za Levkemija išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 1, Duarte
Quetzal Site 7, Los Angeles
Quetzal Site 5, Stanford

Vključevanje udeležencevFaza 3

Starost 18–71 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07504458

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

USC Norris Comprehensive Cancer Center, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

City of Hope Comprehensive Cancer Center, Duarte
UCLA Medical Center, Los Angeles
Stanford Cancer Institute, Stanford

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT04996875

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, La Jolla

Vključevanje udeležencevFaza 3

Starost 18–18 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07509151

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Stanford University, Palo Alto

Vključevanje udeležencevFaza 1

Starost 1–25 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06408194

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Children s Hospital of Los Angeles, Los Angeles

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 5 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT05237986

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Lucille Packard Children's Hospital of Stanford University, Palo Alto

Vključevanje udeležencevFaza 1

18 Months – 39 Years · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT07573111

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of California, Fresno, Clovis
University of California, San Diego, La Jolla
Cedars-Sinai Medical Center, Los Angeles
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

USC Norris Comprehensive Cancer Center, Los Angeles
UCLA Health - Bowyer Oncology Center, Los Angeles
UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06001788

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

Vključevanje udeležencevFaza 2

Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Duarte
Research Site, Los Angeles
Research Site, Palo Alto

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT06137118

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Stanford University, Palo Alto

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06340737

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 13–90 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06533579

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT06810778

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT06580002

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07216443

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT07356154

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site, Duarte
Dren Investigational Site, Irvine
Dren Investigational Site, Redwood City

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

City of Hope Comprehensive Cancer Center, Duarte
Kaiser Permanente-Oakland, Oakland
Lucile Packard Children's Hospital Stanford University, Palo Alto
in še 1

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 18. maj 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Keck School of Medicine of USC, Los Angeles
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT04256317

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
in še 1

Vključevanje udeležencevFaza 1/2

Starost 12–95 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Moores UC San Diego Cancer Center, La Jolla
USC / Norris Comprehensive Cancer Center, Los Angeles
UCLA - Bowyer Oncology Center, Los Angeles
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT05735184

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

City of Hope, Duarte

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40 in več · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT05366881

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

City of Hope - Duarte, Duarte

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 31. okt. 2025 · NCT06549790

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
in še 3

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

San Francisco VA Medical Center, San Francisco, CA, San Francisco

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 14. okt. 2025 · NCT06520098

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

City of Hope Medical Center, Duarte
University of California Los Angeles, Los Angeles
Stanford Cancer Center, Palo Alto

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2025 · NCT06501196

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

Children's Hospital Los Angeles, Los Angeles

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 3 in več · Vsi spoli · Posodobljeno 3. avg. 2025 · NCT06360718

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.